Blanket Purchase Agreement V797D30085-75H71222A00002

Award Date 2/16/22
Last Date to Order 2/14/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) awarded by the Indian Health Service, a civilian federal agency, provides Biomerieux Inc. with a contract vehicle to supply its proprietary BioFire panel reagents and associated diagnostic equipment and services to support the agency's infectious disease testing and pathogen detection needs. The BPA, valued at up to $11,727,635.40, has a performance period extending to May 2029 and is issued under the General Services Administration's In Vitro Diagnostics,...
Biofire Diagnostics, LLC was awarded a blanket purchase agreement by the Department of Health and Human Services Indian Health Service to provide in vitro diagnostics, reagents, and tests. The agreement has a potential value of $477,260.30 and period of performance through August 2026. Two firm fixed price calls totaling $198,824.06 were issued against the agreement to supply respiratory and gastrointestinal diagnostic panels and related supplies to IHS facilities in Fort Duchesne, Utah. The...
The Department of Health and Human Services Indian Health Service awarded a single-award, indefinite delivery contract to Biofire Diagnostics, LLC on September 1, 2020. With a potential value of $550,060, this contract aims to procure BioFire panels and kits to support COVID-19 testing efforts through August 31, 2021. A subsequent firm fixed price delivery order against the contract was awarded on September 2, 2020 to Biofire Diagnostics, LLC for $279,700. The delivery order is for BioFire...
Biomerieux Inc. was awarded a blanket purchase agreement against the General Services Administration Multiple Award Schedule to provide medical diagnostic products and services to the Department of Health and Human Services Indian Health Service. The BPA has a potential value of $249,999 and period of performance through June 2026. Task order calls against the BPA total $13,419.85 for delivery of Biomerieux Previcolor laboratory supplies to support infectious disease testing programs in Phoenix,...
This Blanket Purchase Agreement (BPA) was awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Immucor Inc. The BPA has a total ceiling value of $431,473.00 and a period of performance through June 30, 2027. It was placed against Immucor's existing GSA Schedule contract for in vitro diagnostics, reagents, and test kits. Under this BPA, Immucor will provide a range of in vitro diagnostic equipment, reagents, and testing services to...
The Department of Health and Human Services Indian Health Service awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostic equipment and supplies. The BPA provides a streamlined contract vehicle for the IHS to procure a variety of Biomerieux's proprietary microbiology analyzers, reagents, test kits, controls, and consumables to support infectious disease testing and pathogen detection across IHS medical facilities....
The Department of Health and Human Services Indian Health Service awarded a blanket purchase agreement to Government Scientific Source Inc. for the delivery of Bio-Rad quality control products and laboratory supplies. Under the IDV and associated task orders valued at over $1.4 million, the contractor provides critical materials to support the IHS's scientific research, development, and medical testing programs. Places of performance include facilities in Phoenix, Arizona; Herndon, Virginia; and...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 2 to Biofire Diagnostics LLC, a biotech company specializing in infectious disease diagnostic testing. The BPA, valued at $2,442,440.05, is a single-award contract established against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract...
The Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, awarded a Blanket Purchase Agreement (BPA) contract to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for clinical laboratories. The single-award BPA has a ceiling value of $971,000 and a period of performance through September 30, 2025. Under this BPA, Werfen USA LLC is delivering laboratory supplies, reagents, and equipment to support the clinical...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 (VISN 10) awarded a Blanket Purchase Agreement (BPA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $809,835 single-award BPA, which utilizes Biofire Diagnostics' General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests, will provide reagents to VA facilities in...

The Department of Health and Human Services Indian Health Service awarded Biofire Diagnostics, LLC a blanket purchase agreement under GSA Schedule contract number FSS-65-VII for invitro diagnostics, reagents, and tests. The potential value of the BPA is $329,552.45 for diagnostic products to be ordered through February 14, 2027.

A firm fixed price call against the BPA was placed for $69,870.49 to deliver Biofire panels to the CRSU Lab Department in Parker, Arizona. The period of performance for this task order is expected to end February 15, 2023. No set-aside provision was applied to either the BPA or associated call.

The master GSA Schedule and BPA will facilitate the Indian Health Service's procurement of Biofire Diagnostics' products to support clinical care within American Indian and Alaska Native communities. Timely access to diagnostic testing is crucial for the Indian Health Service to meet its responsibility for providing healthcare to these populations.

Generated 1/4/24, 6:58 PM